# Four Decades of Immunotherapy Dead Ends End With This Injection

- slug: four-decades-of-immunotherapy-dead-ends-end-with-this-injection
- date: 2026-03-20
- category: Biotech & Life Sciences

A team from Mass General Brigham and Dana-Farber Cancer Institute has published results in Cell showing that a single injection of an oncolytic herpes simplex virus can recruit immune cells into glioblastoma tumors and extend survival in a Phase 1 trial — offering a rare bright spot in a cancer t...

---